DekaBank Deutsche Girozentrale - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 79 filers reported holding SERES THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$482,000
-16.5%
67,0000.0%0.00%0.0%
Q4 2021$577,000
+31.7%
67,000
+3.1%
0.00%0.0%
Q3 2021$438,000
-71.3%
65,0000.0%0.00%
-75.0%
Q2 2021$1,527,000
+22.7%
65,0000.0%0.00%0.0%
Q1 2021$1,245,000
+1224.5%
65,000
+99.4%
0.00%
Q2 2019$94,000
-44.0%
32,600
+64.6%
0.00%
-100.0%
Q1 2019$168,000
+124.0%
19,800
+21.5%
0.00%
Q4 2018$75,000
-55.4%
16,300
-17.7%
0.00%
-100.0%
Q3 2018$168,000
-7.7%
19,8000.0%0.00%0.0%
Q2 2018$182,000
+23.8%
19,8000.0%0.00%0.0%
Q1 2018$147,000
-46.4%
19,800
-2.5%
0.00%
-50.0%
Q4 2017$274,0000.0%20,3000.0%0.00%0.0%
Q3 2017$274,000
+16.1%
20,3000.0%0.00%0.0%
Q2 2017$236,000
-61.1%
20,3000.0%0.00%
-71.4%
Q2 2016$606,000
+43.6%
20,300
+20.8%
0.01%
+40.0%
Q1 2016$422,00016,8000.01%
Other shareholders
SERES THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 14,378,802$342,935,0004.38%
SILVERARC CAPITAL MANAGEMENT, LLC 122,700$2,926,0001.30%
COMMODORE CAPITAL LP 145,453$3,469,0001.21%
Asymmetry Capital Management, L.P. 63,259$1,509,0001.04%
Opaleye Management Inc. 250,000$5,963,0000.99%
Ikarian Capital, LLC 500,000$11,924,0000.96%
HighVista Strategies LLC 44,750$1,068,0000.76%
SILVERARC CAPITAL MANAGEMENT, LLC 63,915$1,524,0000.68%
Altium Capital Management LP 104,626$2,495,0000.58%
Integral Health Asset Management, LLC 75,000$1,789,0000.49%
View complete list of SERES THERAPEUTICS INC shareholders